世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Artificial Blood Vessel - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Blood Vessel was estimated to be worth US$ 3824 million in 2024 and is forecast to a readjusted size of US$ 4785 million by 2031 with a CAGR of 3.3% during the fore... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Artificial Blood Vessel was estimated to be worth US$ 3824 million in 2024 and is forecast to a readjusted size of US$ 4785 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover. The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better. Expanding Market Size With continuous advancements in medical technology and intensifying population aging, the market size for artificial blood vessels in China is also expanding steadily. It is estimated that the growth rate of the Chinese market will exceed the global average in the coming years. Technological Innovation Driving Market Development Application of New Materials: The field of artificial blood vessels is moving towards the direction of biodegradability, enhanced biocompatibility, and superior biomechanical properties. The application of biodegradable materials such as polylactic acid (PLA) and polycaprolactone (PCL) is expected to reduce the risks associated with long-term implantation in the body and improve patients' quality of life. The integration of nanotechnology has also brought new opportunities for enhancing the performance of artificial blood vessels. The application of nano-coatings and nano-fibers can enhance the blood vessels' antithrombotic capabilities, antibacterial properties, and durability, making artificial blood vessels safer and more reliable in clinical applications. Advancements in Bioprinting Technology: Bioprinting allows for the manufacturing of artificial blood vessels with complex structures and functions, better matching the physiological characteristics of human blood vessels, thus improving surgical success rates and patients' recovery speeds. Additionally, bioprinting technology enables the customization of artificial blood vessels to meet the diverse needs of different patients and surgical procedures. Intensifying Competition and Rising Market Concentration Competition Among Domestic and Foreign Enterprises: With the entrance of both domestic and foreign enterprises, competition in the artificial blood vessel market is becoming increasingly fierce. Companies need to continuously reduce costs to maintain their competitiveness while increasing investments in innovation and research and development to create differentiated advantages. Rising Market Concentration: The concentration of the Chinese artificial blood vessel market is relatively high, with major market participants occupying a significant market share. This concentration is reflected in diverse product lines, strong brand influence, and extensive market coverage. In the future, with intensifying market competition and industry consolidation, market concentration is expected to further increase. Policies and Health Insurance Support Promoting Market Development Policy Support: Government departments such as the National Development and Reform Commission have increased investments in medical services, promoting healthy capital flows for enterprises through policy support and accelerating industry development. Health Insurance Coverage: The improvement of the health insurance system has made artificial blood vessel treatments more affordable for more patients, further driving the growth of market demand. In the future, with the expansion of health insurance coverage and optimization of reimbursement policies, the demand for artificial blood vessels is expected to further increase. This report aims to provide a comprehensive presentation of the global market for Artificial Blood Vessel, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Blood Vessel by region & country, by Type, and by Application. The Artificial Blood Vessel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Vessel. Market Segmentation By Company Getinge Bard PV Terumo W. L. Gore Japan Lifeline B.Braun LeMaitre Vascular Shanghai Chest Medical Instruments Aortec Medical Technology JIANGSU BIODA LIFE SCIENCE Segment by Type EPTFE Polyethylene Terephthalate Polyurethane Others Segment by Application Aortic Disease Peripheral Artery Disease Hemodialysis By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Artificial Blood Vessel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Artificial Blood Vessel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Artificial Blood Vessel in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Artificial Blood Vessel Product Introduction 1.2 Global Artificial Blood Vessel Market Size Forecast 1.2.1 Global Artificial Blood Vessel Sales Value (2020-2031) 1.2.2 Global Artificial Blood Vessel Sales Volume (2020-2031) 1.2.3 Global Artificial Blood Vessel Sales Price (2020-2031) 1.3 Artificial Blood Vessel Market Trends & Drivers 1.3.1 Artificial Blood Vessel Industry Trends 1.3.2 Artificial Blood Vessel Market Drivers & Opportunity 1.3.3 Artificial Blood Vessel Market Challenges 1.3.4 Artificial Blood Vessel Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Artificial Blood Vessel Players Revenue Ranking (2024) 2.2 Global Artificial Blood Vessel Revenue by Company (2020-2025) 2.3 Global Artificial Blood Vessel Players Sales Volume Ranking (2024) 2.4 Global Artificial Blood Vessel Sales Volume by Company Players (2020-2025) 2.5 Global Artificial Blood Vessel Average Price by Company (2020-2025) 2.6 Key Manufacturers Artificial Blood Vessel Manufacturing Base and Headquarters 2.7 Key Manufacturers Artificial Blood Vessel Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Artificial Blood Vessel 2.9 Artificial Blood Vessel Market Competitive Analysis 2.9.1 Artificial Blood Vessel Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Blood Vessel Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Vessel as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 EPTFE 3.1.2 Polyethylene Terephthalate 3.1.3 Polyurethane 3.1.4 Others 3.2 Global Artificial Blood Vessel Sales Value by Type 3.2.1 Global Artificial Blood Vessel Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Artificial Blood Vessel Sales Value, by Type (2020-2031) 3.2.3 Global Artificial Blood Vessel Sales Value, by Type (%) (2020-2031) 3.3 Global Artificial Blood Vessel Sales Volume by Type 3.3.1 Global Artificial Blood Vessel Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Artificial Blood Vessel Sales Volume, by Type (2020-2031) 3.3.3 Global Artificial Blood Vessel Sales Volume, by Type (%) (2020-2031) 3.4 Global Artificial Blood Vessel Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Aortic Disease 4.1.2 Peripheral Artery Disease 4.1.3 Hemodialysis 4.2 Global Artificial Blood Vessel Sales Value by Application 4.2.1 Global Artificial Blood Vessel Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Artificial Blood Vessel Sales Value, by Application (2020-2031) 4.2.3 Global Artificial Blood Vessel Sales Value, by Application (%) (2020-2031) 4.3 Global Artificial Blood Vessel Sales Volume by Application 4.3.1 Global Artificial Blood Vessel Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Artificial Blood Vessel Sales Volume, by Application (2020-2031) 4.3.3 Global Artificial Blood Vessel Sales Volume, by Application (%) (2020-2031) 4.4 Global Artificial Blood Vessel Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Artificial Blood Vessel Sales Value by Region 5.1.1 Global Artificial Blood Vessel Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Artificial Blood Vessel Sales Value by Region (2020-2025) 5.1.3 Global Artificial Blood Vessel Sales Value by Region (2026-2031) 5.1.4 Global Artificial Blood Vessel Sales Value by Region (%), (2020-2031) 5.2 Global Artificial Blood Vessel Sales Volume by Region 5.2.1 Global Artificial Blood Vessel Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Artificial Blood Vessel Sales Volume by Region (2020-2025) 5.2.3 Global Artificial Blood Vessel Sales Volume by Region (2026-2031) 5.2.4 Global Artificial Blood Vessel Sales Volume by Region (%), (2020-2031) 5.3 Global Artificial Blood Vessel Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Artificial Blood Vessel Sales Value, 2020-2031 5.4.2 North America Artificial Blood Vessel Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Artificial Blood Vessel Sales Value, 2020-2031 5.5.2 Europe Artificial Blood Vessel Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Artificial Blood Vessel Sales Value, 2020-2031 5.6.2 Asia Pacific Artificial Blood Vessel Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Artificial Blood Vessel Sales Value, 2020-2031 5.7.2 South America Artificial Blood Vessel Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Artificial Blood Vessel Sales Value, 2020-2031 5.8.2 Middle East & Africa Artificial Blood Vessel Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Artificial Blood Vessel Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Artificial Blood Vessel Sales Value and Sales Volume 6.2.1 Key Countries/Regions Artificial Blood Vessel Sales Value, 2020-2031 6.2.2 Key Countries/Regions Artificial Blood Vessel Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Artificial Blood Vessel Sales Value, 2020-2031 6.3.2 United States Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Artificial Blood Vessel Sales Value, 2020-2031 6.4.2 Europe Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Artificial Blood Vessel Sales Value, 2020-2031 6.5.2 China Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.5.3 China Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Artificial Blood Vessel Sales Value, 2020-2031 6.6.2 Japan Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Artificial Blood Vessel Sales Value, 2020-2031 6.7.2 South Korea Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Artificial Blood Vessel Sales Value, 2020-2031 6.8.2 Southeast Asia Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Artificial Blood Vessel Sales Value, 2020-2031 6.9.2 India Artificial Blood Vessel Sales Value by Type (%), 2024 VS 2031 6.9.3 India Artificial Blood Vessel Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Getinge 7.1.1 Getinge Company Information 7.1.2 Getinge Introduction and Business Overview 7.1.3 Getinge Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Getinge Artificial Blood Vessel Product Offerings 7.1.5 Getinge Recent Development 7.2 Bard PV 7.2.1 Bard PV Company Information 7.2.2 Bard PV Introduction and Business Overview 7.2.3 Bard PV Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Bard PV Artificial Blood Vessel Product Offerings 7.2.5 Bard PV Recent Development 7.3 Terumo 7.3.1 Terumo Company Information 7.3.2 Terumo Introduction and Business Overview 7.3.3 Terumo Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Terumo Artificial Blood Vessel Product Offerings 7.3.5 Terumo Recent Development 7.4 W. L. Gore 7.4.1 W. L. Gore Company Information 7.4.2 W. L. Gore Introduction and Business Overview 7.4.3 W. L. Gore Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 W. L. Gore Artificial Blood Vessel Product Offerings 7.4.5 W. L. Gore Recent Development 7.5 Japan Lifeline 7.5.1 Japan Lifeline Company Information 7.5.2 Japan Lifeline Introduction and Business Overview 7.5.3 Japan Lifeline Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Japan Lifeline Artificial Blood Vessel Product Offerings 7.5.5 Japan Lifeline Recent Development 7.6 B.Braun 7.6.1 B.Braun Company Information 7.6.2 B.Braun Introduction and Business Overview 7.6.3 B.Braun Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 B.Braun Artificial Blood Vessel Product Offerings 7.6.5 B.Braun Recent Development 7.7 LeMaitre Vascular 7.7.1 LeMaitre Vascular Company Information 7.7.2 LeMaitre Vascular Introduction and Business Overview 7.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 LeMaitre Vascular Artificial Blood Vessel Product Offerings 7.7.5 LeMaitre Vascular Recent Development 7.8 Shanghai Chest Medical Instruments 7.8.1 Shanghai Chest Medical Instruments Company Information 7.8.2 Shanghai Chest Medical Instruments Introduction and Business Overview 7.8.3 Shanghai Chest Medical Instruments Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Shanghai Chest Medical Instruments Artificial Blood Vessel Product Offerings 7.8.5 Shanghai Chest Medical Instruments Recent Development 7.9 Aortec Medical Technology 7.9.1 Aortec Medical Technology Company Information 7.9.2 Aortec Medical Technology Introduction and Business Overview 7.9.3 Aortec Medical Technology Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Aortec Medical Technology Artificial Blood Vessel Product Offerings 7.9.5 Aortec Medical Technology Recent Development 7.10 JIANGSU BIODA LIFE SCIENCE 7.10.1 JIANGSU BIODA LIFE SCIENCE Company Information 7.10.2 JIANGSU BIODA LIFE SCIENCE Introduction and Business Overview 7.10.3 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Offerings 7.10.5 JIANGSU BIODA LIFE SCIENCE Recent Development 8 Industry Chain Analysis 8.1 Artificial Blood Vessel Industrial Chain 8.2 Artificial Blood Vessel Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Artificial Blood Vessel Sales Model 8.5.2 Sales Channel 8.5.3 Artificial Blood Vessel Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（artificial）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
